welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
not yet recruiting

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy (REACH-DMD)

key information

study id #: NCT04587908

condition: Duchenne Muscular Dystrophy

status: not yet recruiting

purpose:

The purpose of this study is to evaluate the efficacy and safety of TAS-205 in patients with Duchenne muscular dystrophy.

intervention: TAS-205, Placebo

mechanism of action: HPGDS inhibitor to modulate effects of inflammation

results: https://clinicaltrials.gov/ct2/show/results/NCT04587908?view=results

last updated: October 22, 2020